Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Quick Stats
May 22, 202656.5
AI Score
HOLD0.89
Volume Ratio
May 14, 2026
Next Earnings
13
+ve Days (30d)
16
-ve Days (30d)
DYN Stock Summary
Last updated May 22, 2026
DYN is currently trading at $17.37, positioned above its 200-day moving average of $17.16, indicating a long-term uptrend. The stock has a 52-week range of $8.06 to $25.
Technical Analysis: The 50-day moving average stands at $18.25, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 47.611, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.186, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates DYN at 56.5/100 with a HOLD recommendation.
DYN (Dyne Therapeutics, Inc. Common Stock) Indicators
Last updated May 22, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 47.611 |
| CMF (20) | -0.186 |
| ROC (10) | -0.653 |
| ADX (14) | 13.653 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.292 |
| AROONOSC (14) | -64.286 |
| WILLAMS %R (14) | -47.917 |
| MFI (14) | 44.832 |
DYN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
DYN Price vs Max Options Open Interest
DYN Max Change In Options Open Interest
DYN Options - Sort by Max open Interest (near term)
22nd May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DYN Daily Out of Money Options - Sort by Max open Interest (near term)
22nd May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DYN Daily In the Money Options - Sort by Max open Interest (near term)
22nd May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DYN Most Active Options by Volume(near term)
22nd May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Dyne Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
DYN Moving Averages Analysis
Dyne Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on May 22, 2026
DYN (Dyne Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated May 22, 2026
| Days | MA |
|---|---|
| 10 | 17.56 |
| 20 | 17.67 |
| 30 | 18.28 |
| 50 | 18.25 |
| 100 | 17.69 |
| 200 | 17.16 |
DYN Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.9 billion |
| Earnings/Share ($) | -3.11 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.0771 |
| EPS Estimate Next Year ($) | -3.0081 |
| WallStreet Target Price ($) | 38.1875 |
| Most Recent Quarter |